当前位置: X-MOL 学术Psychological Services › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Decreases in psychiatric symptoms persist following exposure-based group therapy for sexual violence victimization among incarcerated women.
Psychological Services ( IF 1.9 ) Pub Date : 2021-07-22 , DOI: 10.1037/ser0000570
Marie E Karlsson 1 , Melissa J Zielinski 2 , Maegan Calvert 3 , Ana J Bridges 3
Affiliation  

Survivors Healing from Abuse: Recovery through Exposure (SHARE) is a brief, exposure-based group treatment for incarcerated female survivors of sexual violence. Preliminary evaluations of SHARE showed declines in depression and posttraumatic stress disorder (PTSD) symptoms from pre- to posttreatment. However, prior investigations have not included a longitudinal follow-up period and thus knowledge of whether therapeutic benefits persist following the termination of the group is lacking. Here, we examined data from 57 incarcerated women who completed SHARE and provided follow-up data while still incarcerated (M = 95 days posttreatment). Results from a one-way repeated-measures ANOVA showed significant reductions in PTSD and depression symptoms from pre- to posttreatment (large effect sizes), with symptoms further reduced during the follow-up period. In addition, McNemar tests showed a significant reduction in the proportion of participants at or above the clinical cut-off for probable PTSD and depression from pre- to posttreatment as well as from posttreatment to the follow-up assessment. Together, results suggest that the therapeutic benefits of SHARE persist after treatment is completed. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

中文翻译:


针对被监禁妇女中的性暴力受害者,进行基于暴露的团体治疗后,精神症状持续减少。



虐待幸存者治愈:通过暴露恢复 (SHARE) 是一项针对被监禁的性暴力女性幸存者的简短、基于暴露的团体治疗。 SHARE 的初步评估显示,从治疗前到治疗后,抑郁症和创伤后应激障碍 (PTSD) 症状有所下降。然而,先前的调查并未包括纵向随访期,因此缺乏关于该组终止后治疗效果是否持续的知识。在这里,我们检查了 57 名完成 SHARE 的被监禁女性的数据,并提供了仍被监禁期间的后续数据(M = 治疗后 95 天)。单向重复测量方差分析的结果显示,从治疗前到治疗后,PTSD 和抑郁症状显着减轻(效应量大),并且在随访期间症状进一步减轻。此外,麦克尼马尔测试显示,从治疗前到治疗后以及从治疗后到后续评估,处于或高于可能的 PTSD 和抑郁症临床临界值的参与者比例显着减少。总之,结果表明 SHARE 的治疗效果在治疗完成后仍然持续存在。 (PsycInfo 数据库记录 (c) 2022 APA,保留所有权利)。
更新日期:2021-07-22
down
wechat
bug